These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 12138989

  • 1. Gender and age in the biochemical assessment of cure of acromegaly.
    Freda PU, Landman RE, Sundeen RE, Post KD.
    Pituitary; 2001 Aug; 4(3):163-71. PubMed ID: 12138989
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU, Post KD, Powell JS, Wardlaw SL.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [Abstract] [Full Text] [Related]

  • 3. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC, Rossi A, Martinelli CE, Machado HR, Moreira AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [Abstract] [Full Text] [Related]

  • 4. Remission criteria for the follow-up of patients with acromegaly.
    Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N, Erdogan G.
    Eur J Endocrinol; 2004 Apr; 150(4):465-71. PubMed ID: 15080775
    [Abstract] [Full Text] [Related]

  • 5. Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.
    Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Bruce JN.
    Pituitary; 2003 Apr; 6(4):175-80. PubMed ID: 15237928
    [Abstract] [Full Text] [Related]

  • 6. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O, Beauregard C, Hardy J.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [Abstract] [Full Text] [Related]

  • 7. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC.
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [Abstract] [Full Text] [Related]

  • 8. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J, Rabijewski M, Zgliczyński W.
    Endokrynol Pol; 2005 Jan; 56(6):862-70. PubMed ID: 16821203
    [Abstract] [Full Text] [Related]

  • 9. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [Abstract] [Full Text] [Related]

  • 10. Current concepts in the biochemical assessment of the patient with acromegaly.
    Freda PU.
    Growth Horm IGF Res; 2003 Aug; 13(4):171-84. PubMed ID: 12914750
    [Abstract] [Full Text] [Related]

  • 11. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
    Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V.
    Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
    [Abstract] [Full Text] [Related]

  • 12. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, Cappabianca P, Lombardi G.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [Abstract] [Full Text] [Related]

  • 13. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD, Bonert VS, Mirocha JM, Melmed S.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [Abstract] [Full Text] [Related]

  • 14. Biochemical evidence in favor of revising Cortina criteria.
    Webb SM, Sucunza N, Barahona MJ.
    J Endocrinol Invest; 2005 Feb; 28(11 Suppl International):84-6. PubMed ID: 16625854
    [Abstract] [Full Text] [Related]

  • 15. Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.
    Sherlock M, Aragon Alonso A, Reulen RC, Ayuk J, Clayton RN, Holder G, Sheppard MC, Bates A, Stewart PM.
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):74-81. PubMed ID: 19178529
    [Abstract] [Full Text] [Related]

  • 16. Gender- and age-related differences in the endocrine parameters of acromegaly.
    Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G.
    J Endocrinol Invest; 2002 Jun; 25(6):532-8. PubMed ID: 12109625
    [Abstract] [Full Text] [Related]

  • 17. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A, Mendoza V.
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
    Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, Strasburger CJ, Schöfl C, Pfeiffer AF.
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1254-62. PubMed ID: 18171702
    [Abstract] [Full Text] [Related]

  • 19. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M.
    Neuroendocrinology; 2006 Apr; 83(3-4):200-4. PubMed ID: 17047383
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of two highly sensitive assays for serum IGF-1 and GH determination following oral glucose tolerance test in healthy controls.
    García de la Torre N, Durán A, de Miguel P, Angel Díaz J, Hervás F, Puente M, Charro A.
    Endocrinol Nutr; 2008 Mar; 55(3):111-6. PubMed ID: 22967876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.